Objective: Adipocytes accumulated in the visceral area change their function to induce tumor necrosis factor-a (TNF-a) secretion with concomitant matrix metalloproteinase (MMP)-3 induction in mice. This study was performed to clarify the role of macrophages (Mf)-secreted MMP on the functional changes in adipocytes using a culture system. Design: Cultures of 3T3-L1 adipocytes with THP-1 Mf or the Mf-conditioned medium were used to investigate the role of Mf-MMP on the TNF-a gene in 3T3-L1 adipocytes by the addition of MMP inhibitors. For animal experiments, male C57BL/6J mice were rendered insulin resistant by feeding a high-fat diet, and the expression of an Mf marker F4/80, and MMP-3 genes in mesenteric and subcutaneous fat tissue specimens were examined. Results: Mf-conditioned media (Mf-CM) increased the levels of TNF-a mRNA expression in 3T3-L1 adipocytes, and these adipocyte responses were abolished by treatment with GM6001, a broad-spectrum MMP inhibitor, or NNGH (N-isobutyl-N-(4-methoxyphenylsulfonyl)-glycylhydroxamic acid), an MMP-3 inhibitor. The activated form of MMP-3 enhanced glycerol release as well as TNF-a protein secretion from 3T3-L1 adipocytes. The incubation of adipocytes with MMP-3 inhibited insulin-induced glucose uptake in adipocytes. Furthermore, a high-fat intake increased the expression of MMP-3, decreased the insulin-induced glucose uptake of adipocytes and induced expression of F4/80 in mesenteric fat tissue of C57BL/6 mice. Conclusion: Mf may cause a pathological link with surrounding adipocytes through the secretion of MMP-3 followed by TNF-a expression in adipocytes in visceral fat tissue.
Introduction
Disturbed insulin sensitivity plays an important role in the accumulation of various metabolic disorders, and has been recognized as 'metabolic syndrome'. 1, 2 In accordance with the clinical significance of evaluation of visceral fat accumulation in metabolic syndrome, it has become evident that visceral fat has direct interaction with other tissues, such as muscles, liver or vessel walls, through the secretion of several molecules regulating the insulin sensitivity in tissues. 3, 4 The transplantation of cultured cells into the intramesenteric space of mature mice has been established as an adequate mode for the analyses of the interaction between visceral fat and insulin sensitivity. 5 The mice with transplanted cultured adipocytes showed that visceral fat, and not subcutaneous fat, secretes the tumor necrosis factor-a (TNF-a), and the secreted molecules actually disturb the insulin sensitivity based on the decreased insulin action in tissues. 5 The accumulated visceral fat caused drastic changes in expression of matrix metalloproteinase (MMP) family genes, among which MMP-3 potentiated free fatty acid-induced TNF-a secretion from adipocytes. 6 Therefore, the MMP-3 activity in visceral fat seems to be directly linked to cytokine expression in adipocytes.
There is an infiltration of macrophages (Mf) in the accumulated fat tissues, and active Mf cause a pathological inter-relationship with surrounding adipocytes in visceral fat, which leads to the progression of insulin resistance.
A variety of inflammatory bioactive molecules plays an important role in pathological interaction between Mf and adipocytes in visceral fat. [8] [9] [10] [11] [12] [13] [14] An overexpression of monocyte chemoattractant protein (MCP)-1 in adipose tissues causes macrophage recruitment and insulin resistance in mice. 10, 11 TNF-a secretion is highly related to the free fatty acid (FFA)-induced inflammatory changes in both adipocytes and Mf. [12] [13] [14] [15] The peroxisome proliferator-activated receptor activation in Mf is able to regulate the FFA-induced TNF-a secretion from adipocytes. 16 The present study was designed to identify the role of MMP-3 in the interaction between Mf and adipocytes for TNF-a gene induction. Conditioned media from Mf (Mf-CM) increased the TNF-a mRNA expression in adipocytes. The induced levels of TNF-a mRNA were largely abolished by treatment with GM6001, a broad-spectrum MMP inhibitor, or N-isobutyl-N-(4-methoxyphenylsulfonyl)-glycylhydroxamic acid (NNGH), an MMP-3 inhibitor. The active form of MMP-3 enhanced release of TNF-a and glycerol from 3T3-L1 adipocytes, and inhibited insulin-induced glucose uptake into the cells. The MMP-3 expression in Mf, in addition to adipocytes, is potentially important for the development of a pathological link between Mf and adipocytes through TNF-a secretion in visceral fat tissue.
Methods
Cell culture and preparation of Mf conditioned media 3T3-L1 cells (American Type Culture Collection, Manassas, VA, USA) were cultured and differentiated into adipocytes as described previously. 16 The human monocytic cell line THP-1 (American Type Culture Collection) was cultured in RPMI 1640 supplemented with l-glutamine (GibcoBRL, Tokyo, Japan) penicillin/streptomycin (100 U per 100 mg ml À1 ; GibcoBRL) and 10% fetal bovine serum (GibcoBRL, medium A). To allow the monocytes to differentiate into adherent macrophages, THP-1 cells were washed in phosphate-buffered saline (calcium-and magnesium-free; GibcoBRL, buffer A) and resuspended in fresh medium A containing phorbol 12-myristate-13-acetate (50 ng ml À1 PMA; Sigma, St Louis, MO, USA) for 3 days (at day 0), and were incubated for 3 more days in Dulbecco's modified Eagle's medium (DMEM) supplemented with 2% bovine serum albumin (BSA). At day 3, the culture media were collected, centrifuged and stored as Mf-CM. Control CM were prepared by incubating the THP-1 cells with DMEM supplemented with 2% BSA for 3 days (THP1-CM). Mf-CM and THP1-CM were stored at À80 1C until use. The differentiation of THP1 to mature Mf was evaluated by the quantification of CD11b and CD68 mRNA levels using real-time PCR. The differentiated macrophages with CD11b and CD68 mRNA levels of more than two fold greater than those in THP-1 were used for further experiments. Co-culture of adipocytes and Mf was performed using transwell inserts with 0. 17 The quantification of a given gene, expressed as relative mRNA level compared with a control, was calculated after normalization to 18S rRNA.
Enzyme-linked immunosorbent assay
Serum-starved 3T3-L1 adipocytes were incubated with 100 mg ml À1 human MMP-3 (Sigma) for 1-3 days, and the culture medium was assayed for mouse TNF-a using commercial enzyme-linked immunosorbent assay (ELISA) kits (BioLegend, San Diego, CA, USA) according to the manufacturer's instructions as described previously.
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Glycerol release measurement Differentiated 3T3-L1 adipocytes were incubated with DMEM supplemented with 1% FFA-free BSA for 2 days, and then treated with same medium with Mf-CM at 50% of volume, THP1-CM at 50% of volume or human MMP-3 at 100 mg ml
À1
, in the absence or presence of 60 mM NNGH for 6 h. The concentrations of glycerol in the media were determined using a free glycerol determination kit (Sigma) following the manufacturer's protocol.
2-Deoxyglucose uptake assay
Differentiated 3T3-L1 adipocytes were preincubated in serum-starved DMEM with 50% Mf-CM, 50% THP1-CM or human MMP-3 at 100 mg ml À1 , in the absence or presence of 60 mM NNGH for 6 h. Single adipocytes were prepared from mesenteric or subcutaneous fat of mice, fed with high-fat or regular diet as described. 14 The cells were incubated in DMEM without serum for 2 h at 37 1C, and then either treated or not treated with 100 nM insulin for 15 min at 37 1C, as described previously. 18 After stimulation, 10 mM H-labeled radioactivity was counted using a scintillation counter (LS-6500; Beckman Coulter Inc., Fullerton, CA, USA).
Animals and animal care
Male C57BL/6J mice (Charles River, Wilmington, MA, USA) were rendered insulin resistant by feeding a high-fat diet consisting of 20% protein, 20% carbohydrate and 60% fat (Research Diet, New Brunswick, NJ, USA) starting at 8 weeks of age for 2 weeks as described previously.
14 Control mice were fed a standard diet consisting of 4.5% fat (Research Diet). Mesenteric and subcutaneous fat tissue specimens were resected, and total RNA was isolated as described previously. 14 All applicable institutional and governmental regulations concerning the ethical use of animal were followed during this research. All animal care and procedures were approved by the Animal Care Committee of Chiba University School of Medicine as described previously.
Western blot analysis
Membranes from fat tissue specimens were prepared and solubilized in solubilization buffer (200 mM Tris-maleate, pH 6.5, 2 mM CaCl 2 , 0.5 mM PMSF, 2.5 mM leupeptin and 1% Triton X-100) as previously described. 19 The protein concentrations were determined using the BCA Protein Assay Reagent (Pierce, Rockford, IL, USA). For immunoblotting, equal amounts of membrane protein, protein extracted from pelleted beads, or concentrated media were separated by 10% SDS-PAGE after heating to 95 1C for 5 min under reducing conditions, and transferred to a nitrocellulose membrane. The blots were incubated with antibody against MMP-3 (SC-6839, 1:100 dilution), followed by peroxidase-conjugated anti-goat IgG, and then they were developed using the ECL detection reagents (Amersham Pharmacia, Piscataway, NJ, USA). The signals were quantified by densitometric scanning using the NIH image software program.
Statistical analysis
Results are presented as mean±s.d. Statistical significance between two groups was evaluated by Student's t-test. Statistical significance among several groups was performed using a one-way ANOVA. A value of Po0.05 was considered to be significant. Mf-CM dose-dependently increased TNF-a mRNA expression at the concentrations from 10 to 50% (Figure 1c ). There were no obvious changes in the morphology of the adipocytes, and there was no apparent toxicity with either Mf-CM or THP1-CM (data not shown).
Results

Effects of Mf
Role of Mf-derived factors in induction of TNF-a mRNA in adipocytes The expression of the MMP-3 gene is one of most induced genes in accumulated visceral fat tissues, and MMP-3 induces the TNF-a secretion from adipocytes. 6 To explore the molecular mechanisms of the above observed interaction between Mf and adipocytes, the role of MMP secreted from Mf in the induction of TNF-a mRNA was investigated in adipocytes. The expression of MMP genes significantly increased in Mf in comparison to those in THP-1 cells (Figure 2 ). Among them, MMP-9 was most induced gene in Mf (199-fold). The expression of MMP-3 and -12 genes was hardly detected in THP-1 cells. These results raise the possibility that Mf-secreted MMP enhances the expression of the TNF-a gene in 3T3-L1 adipocytes in co-culture system. Mf-CM treated with various types of MMP inhibitors was added to 3T3-L1 adipocytes to examine the changes of TNF-a gene expression in 3T3-L1 adipocytes (Figure 3 ). GM6001, a broad-spectrum MMP inhibitor, markedly altered 
the stimulatory effects of Mf-CM on the gene expression of TNF-a (À42%). The gelatinases inhibitor, CTT and an MMP-3 inhibitor, NNGH were used to determine the role of the gelatinases (MMP-2 and -9) and MMP-3 on the TNF-a gene expression in 3T3-L1 adipocytes. The stimulatory effect of Mf-CM on the TNF-a gene expression was not significantly inhibited by CTT treatment. In contrast, the induction of TNF-a by Mf-CM was markedly inhibited by NNGH treatment (À56%), suggesting an important role for MMP-3 in the adipocyte function. To determine if MMP-3 is the soluble mediator causing TNF-a induction in adipocytes, 3T3-L1 adipocytes were treated with activated MMP-3, and TNF-a mRNA expression and release were measured. MMP-3 treatment significantly increased TNF-a mRNA expression by 3.2-fold (Figure 4a) , and the increases were also detected after 50-200 ng ml À1 MMP-3 treatments for 8 h (data not shown). Figure 4b shows that MMP-3 treatment (100 ng ml À1 ) increased TNF-a secretion in a time-dependent manner.
Active MMP-3 induces lipolysis, and reduces insulin-induced glucose incorporation in 3T3-L1 adipocytes In order to determine the role of Mf-derived MMP-3 in the functional changes of adipocytes to induce the TNF-a mRNA expression in adipocytes, the effect of MMP-3 on the lipolysis of 3T3-L1 adipocyte was analyzed (Figure 5a ). The glycerol release was significantly increased in the media of 
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High-fat intake induced the expression of MMP-3 in mesenteric fat tissues as well as the induction of F4/80 gene To assess the expression of MMP-3 gene in adipose tissue Mf, the levels of MMP-3 mRNA were examined in mesenteric fat tissue from mice fed with high-fat diet in relation to the expression of the F4/80 gene, an Mf-specific antigen 15, 20 ( Figure 6 ). High-fat intake for 2 weeks significantly induced the expression level of F4/80 mRNA in mesenteric fat tissue by 2.2-fold in comparison to the level in the control mice.
The levels of MMP-3 and TNF-a genes in mesenteric fat tissue were also significantly induced by 2.8-and 2.5-fold in the mice fed the high-fat diet compared in the control mice, respectively. The expression of F4/80, MMP-3 or TNF-a gene in subcutaneous fat tissues was not significantly different between the mice fed with regular chow and high-fat diet. The MMP-3 protein expression was analyzed in either visceral or subcutaneous fat tissue specimens (Figure 7a ). The MMP-3 protein levels in visceral fat tissues, but not in subcutaneous fat, were significantly higher in the mice fed with a high-fat diet than those fed with regular chow. The insulin-induced glucose uptake activity in the adipocytes prepared from visceral fat tissues was significantly decreased in the mice fed with high-fat diet in comparison to those consuming regular chow (Figure 7b ). These results indicate 
Discussion
The current study demonstrated that Mf-CM influences the expression of TNF-a from 3T3-L1 adipocytes. This induction of TNF-a is attenuated by an MMP-3 inhibitor, NNGH. The active form of MMP-3 showed the capability for the induction of lipolysis and the inhibition of the insulininduced glucose uptake, as well as for the enhanced secretion of TNF-a. These findings suggest that MMP-3 thus plays a role in the modulation of the adipocyte function from Mf in adipose tissues. Recent observations suggested that inflammatory conditions evoked in fat tissues recruit activated Mf, possibly enhancing and/or continuing the chronic process in fat tissues. 8, 9 TNF-a is suspected to be one of the key players among many cytokines in the interactive modification of function in Mf and adipocytes. 4, 7 Based on the results obtained herein using a culture system, infiltrating Mf may therefore modify the maturation process and secretion level of TNF-a in adipocytes in fat tissues. The expression of TNF-a is observed in 3T3-L1 preadipocytes, and declines gradually after the beginning of maturation in the presence of inducers. 21 The mice with transplanted cultured 3T3-L1 cells
showed that the transplanted adipocytes in visceral space, and not subcutaneous space, secret TNF-a and the secreted molecules actually disturb the systemic insulin sensitivity, based on the decreased insulin action in tissues. 5 The induced expression of TNF-a is also observed in the adipocytes in visceral spaces of subcutaneously lipectomized mice. 22 Therefore, the adipocytes that accumulate in visceral space are potentially sensitive to induce the TNF-a gene expression in mice. Recent studies have indicated that extracellular matrix (ECM) degradation is important for adipogenesis. MMPs are essential for proper matrix remodeling, a process that takes place during adipose tissue formation. Human mature adipocytes secret MMP-2 and -9 and their proteolytic activities are induced during differentiation of murinecultured adipocytes. 23 mRNA levels for MMP-2, MMP-3, MMP-12, MMP-14, MMP-19 and TIMP-1 are strongly induced in obese adipose tissues in a genetic or a diet-induced model of obesity. 24 The treatment of cultured preadipocytes with either synthetic MMP inhibitors or neutralizing antibodies decreases differentiation. 22 These previous studies using cultured adipocytes suggest that MMP activity is required for adipocyte conversion. The body weight of MMP-3-deficient mice is increased in comparison to that of wild-type mice, as is the weight of the isolated subcutaneous and gonadal fat deposits. 25 MMP-11-deficient mice develop adipocyte hypertrophy in comparison to wild-type mice. 26 Furthermore, the membrane-anchored metalloproteinase, MT1-MMP, acts as a 3D-specific adipogenic factor that directs the dynamic adipocyte-ECM interactions critical to WAT development. 27 These studies using knockout models revealed critical roles of MMPs in fat tissue development and adipogenesis, and possibly also in fat accumulation accompanied with insulin resistance. A recent study reported that the MMP-3 expression levels are negatively correlated with percent body fat, and the MMP-3 gene variants are associated with both BMI and type 2 diabetes in Pima Indians. 28 The mice with transplanted cultured 3T3-L1 cells showed that the transplanted adipocytes in the visceral space, and Macrophage MMP-3 for the function of adipocytes H Unoki et al not subcutaneous space, increased TNF-a gene expression. 5 A microarray analysis revealed that the MMP-3 gene expression is drastically induced in addition to TNF-a. 6 Therefore, the MMP-3 gene expression in visceral fat seems to be directly linked to cytokine expression in adipocytes. The current study showed that the active form of MMP-3 enhanced glycerol release, as well as TNF-a protein secretion, from 3T3-L1 adipocytes. The incubation of adipocytes with MMP-3 inhibited insulin-induced glucose uptake in adipocytes. Therefore, the induction of MMP-3 gene expression may modulate lipid and glucose metabolism in visceral adipocytes, leading to the induction of TNF-a secretion. The treatment of 3T3-L1 preadipocytes with the MMP inhibitor Ilomastat has been shown to prevent their differentiation into adipocytes. 29 The subcutaneous administration of MMP inhibitor KB-R7785 reduced the plasma glucose and insulin levels with a concomitant decrease in the TNF-a production in KK-A y mice. 30 These observations indicate that Mf-MMP may thus play a functional role in the induction of TNF-a gene expression impairing insulin sensitivity in adipocytes.
Recently, MMP-3 has been shown to be a signaling molecule via the ERK pathway, followed by proinflammatory cytokine induction, and induce superoxide generation in microglia. 31 Moreover, activated MMP-3 is present in the nuclear compartment of malignant and nontransformed hepatocytes, and is associated with the onset of apoptosis. 32 These studies suggested a novel function of MMP-3 as a signaling molecule active for intracellular functions. The current results showed that high-fat intake induced a decrease in insulin-induced glucose incorporation in adipocytes, as well as an increase in Mf-infiltration and TNF-a expression in visceral fat tissue. Therefore, MMP-3 may affect the lipid metabolism of adipocytes through the ECM degradation and the activation of other extracellular and intracellular molecules leading to the lipolysis and glucose incorporation. Therefore, Mf-derived MMP-3 may modulate the secretion of TNF-a in adipocytes by modulating the lipid metabolism, which is tightly linked to visceral fat accumulation and systemic insulin resistance.
In conclusion, this study suggests that MMP-3 is important for the function of pathological link between Mf and adipocytes, which leads to insulin resistance in metabolic syndrome through the regulation of cytokine expression such as TNF-a. The further elucidation of the role of MMP-3 and its secretion from activated Mf and adipocytes is therefore expected to contribute to the elucidation of the unexpected relationship between chronic inflammation and disturbed insulin sensitivity in humans.
